Meson Haji Basha
Meson Haji Basha has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- C. Gladis Raja Malar
Vel Tech Engineering College
3 shared publications - Kammela Prasada Rao
Department of Chemistry, Bapatla Engineering College
3 shared publications Chennamsetty Subramanyam
2 shared publications- Mohan Seelam
Department of Chemistry, Bapatla Engineering College, Bapatla
2 shared publications - Vedula Naga Lakshmi
Department of Chemistry, Ch.S.D.St.Theresa’s College for Women (A)
2 shared publications - Chennamasetty Subramanyam
Department of Chemistry, Bapatla Engineering College
1 shared publication
Latest Publications
- 19 February 2026
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 201 (6) , 825-839
Design and synthesis of new bis(α-aminophosphonates) via ultrasound-driven nano-BF 3 ·SiO 2 catalysis targeting α-amylase inhibition: In silico ADME and molecular docking study
- 19 February 2026
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 201 (6) , 825-839
Design and synthesis of new bis(α-aminophosphonates) via ultrasound-driven nano-BF 3 ·SiO 2 catalysis targeting α-amylase inhibition: In silico ADME and molecular docking study
- 30 December 2024
- Published by ACG Publications in Organic Communications
- Vol. 17 (4) , 249-264
Ultrasound-assisted synthesis of α-aminophosphonates using nano ZnO catalyst: evaluation of their anti-diabetic activity
A more efficient and environmentally friendly way of synthesizing α-aminophosphonates is achieved by employing nano-ZnO to catalyze the Kabachnik-Fields reaction under ultrasonication within a solvent-free environment. Before synthesis, molecular docking and in silico ADME analysis were used to assess each molecule's drug-like characteristics and ability to inhibit α-amylase and α-glucosidase. The newly synthesized compounds' in vitro inhibitory effects on α-amylase and α-glucosidase were also evaluated, and their structure was confirmed using spectroscopic investigation. The target enzyme was effectively inhibited by most of the substances. In comparison to the reference drug, acarbose (IC50, 106.5±0.6 μg/mL), compounds 4d (IC50, 102.2±0.3 μg/mL), 4h (IC50, 102.9±0.4 μg/mL), which contained a 2H-1,3-benzodioxol-5-yl moiety, and 4i (IC50, 103.9±0.5 μg/mL) showed the strongest inhibitory activity. The enzyme inhibition of the remaining compounds ranged from moderate to good.rnrn
- 30 December 2024
- Published by ACG Publications in Organic Communications
- Vol. 17 (4) , 249-264
Ultrasound-assisted synthesis of α-aminophosphonates using nano ZnO catalyst: evaluation of their anti-diabetic activity
A more efficient and environmentally friendly way of synthesizing α-aminophosphonates is achieved by employing nano-ZnO to catalyze the Kabachnik-Fields reaction under ultrasonication within a solvent-free environment. Before synthesis, molecular docking and in silico ADME analysis were used to assess each molecule's drug-like characteristics and ability to inhibit α-amylase and α-glucosidase. The newly synthesized compounds' in vitro inhibitory effects on α-amylase and α-glucosidase were also evaluated, and their structure was confirmed using spectroscopic investigation. The target enzyme was effectively inhibited by most of the substances. In comparison to the reference drug, acarbose (IC50, 106.5±0.6 μg/mL), compounds 4d (IC50, 102.2±0.3 μg/mL), 4h (IC50, 102.9±0.4 μg/mL), which contained a 2H-1,3-benzodioxol-5-yl moiety, and 4i (IC50, 103.9±0.5 μg/mL) showed the strongest inhibitory activity. The enzyme inhibition of the remaining compounds ranged from moderate to good.rnrn
- 28 June 2022
- Published by ACG Publications in Organic Communications
- Vol. 15 (2) , 167-183
Nano TiO2.SiO2 catalyzed, microwave assisted synthesis of new α-aminophosphonates as potential anti-diabetic agents: In silico ADMET and molecular docking study
Using microwave irradiation, an effective and greener method for the synthesis of α-aminophosphonates via Kabachinic-Fields reaction in a solvent-free environment is devised. An in silico ADMET and molecular docking analysis was performed on all of the compounds to get insight into their drug likeliness behaviour as well as their capacity to block the enzyme α-amylase (PDB ID: 3IJ8). The compounds with the highest binding affinity and pharmacokinetic properties were developed. The newly created compounds were spectroscopically examined to establish their structure, and all of them were tested for in vitro α-amylase inhibitory action. The compounds 7j (IC50: 99.9±0.3 μg/mL) and 7e (IC50: 102.0±0.7 μg/mL) showed stronger inhibitory efficacy than acarbose, the reference medication. The compounds 7g (IC50, 106.7±0.4 μg/mL), 7d (IC50, 108.4±0.3 μg/mL), 7h (IC50, 115.0±0.4 μg/mL), and 7f (IC50, 119.2±0.4 μg/mL) have shown to inhibit the target enzyme significantly.When compared to the reference drug, Acarbose (IC50, 102.6±0.8 μg/mL), all of the remaining compounds showed modest to good inhibition with IC50 values ranging from 125.6±0.6 to 152.7±0.2 μg/mL. The findings revealed that the vast majority of these drugs have strong α-amylase inhibitory action.
- 28 June 2022
- Published by ACG Publications in Organic Communications
- Vol. 15 (2) , 167-183
Nano TiO2.SiO2 catalyzed, microwave assisted synthesis of new α-aminophosphonates as potential anti-diabetic agents: In silico ADMET and molecular docking study
Using microwave irradiation, an effective and greener method for the synthesis of α-aminophosphonates via Kabachinic-Fields reaction in a solvent-free environment is devised. An in silico ADMET and molecular docking analysis was performed on all of the compounds to get insight into their drug likeliness behaviour as well as their capacity to block the enzyme α-amylase (PDB ID: 3IJ8). The compounds with the highest binding affinity and pharmacokinetic properties were developed. The newly created compounds were spectroscopically examined to establish their structure, and all of them were tested for in vitro α-amylase inhibitory action. The compounds 7j (IC50: 99.9±0.3 μg/mL) and 7e (IC50: 102.0±0.7 μg/mL) showed stronger inhibitory efficacy than acarbose, the reference medication. The compounds 7g (IC50, 106.7±0.4 μg/mL), 7d (IC50, 108.4±0.3 μg/mL), 7h (IC50, 115.0±0.4 μg/mL), and 7f (IC50, 119.2±0.4 μg/mL) have shown to inhibit the target enzyme significantly.When compared to the reference drug, Acarbose (IC50, 102.6±0.8 μg/mL), all of the remaining compounds showed modest to good inhibition with IC50 values ranging from 125.6±0.6 to 152.7±0.2 μg/mL. The findings revealed that the vast majority of these drugs have strong α-amylase inhibitory action.